1. Upregulated BclGL expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus
- Author
-
Luo, Na, Wu, Yi, Chen, Yongwen, Yang, Zhao, Guo, Sheng, Fei, Lei, Zhou, Di, Yang, Chengying, Wu, Shengxi, Ni, Bing, Hao, Fei, and Wu, Yuzhang
- Subjects
- *
APOPTOSIS , *CHEMICAL inhibitors , *GLYCOPROTEINS , *GENE expression , *T cells , *SYSTEMIC lupus erythematosus , *DNA microarrays , *IMMUNE response , *HOMEOSTASIS , *PATIENTS - Abstract
Abstract: Increased lymphocyte apoptosis has been suggested to contribute to the development of systemic lupus erythematosus (SLE), but the critical factors involved in the apoptotic pathways are still unknown. By long serial analysis of gene expression (LongSAGE) profiles and microarray analyses, a novel apoptosis-related gene BclGL expression was found significantly increased in peripheral blood CD4+ T cells of SLE patients, which was correlated with the enhanced CD4+ T cells apoptosis, anti-nuclear antibody (ANA) titer and proteinuria. In vitro, BclGL expression could be specially upregulated by SLE serum stimulation and positively correlated with induced CD4+ T cell apoptosis. Enforcing BclGL overexpression by lentivirus could directly enhance CD4+ T cell apoptosis, but these apoptosis-inducing effects could be partially inhibited by knockdown of BclGL expression. Collectively, these results indicate that increased BclGL expression may contribute to the aberrant CD4+ T cell apoptosis which causes an inappropriate immune response and impaired homeostasis in SLE. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF